This grant, offered by the Department of Arthritis, Musculoskeletal, and Skin Diseases, is specifically designed to fund exploratory clinical trials. It seeks to support innovative research initiatives focused on advancing the understanding and treatment of conditions affecting joints, muscles, bones, and skin. This funding opportunity, identified as an R61 mechanism and requiring a clinical trial component, is a re-issue of a previous program (PAR-24-035). While the core purpose remains consistent, the current version incorporates specific changes in Section V. These modifications are a result of the ‘Simplifying Review of Research Project Grant Applications’ policy, aiming to streamline the application and review process. All other fundamental aspects of this grant opportunity remain unchanged from its prior iteration, continuing to invite proposals that promise significant contributions to these vital health fields.
Opportunity ID: 357602
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-279 |
| Funding Opportunity Title: | Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 09, 2024 |
| Last Updated Date: | Dec 09, 2024 |
| Original Closing Date for Applications: | Nov 02, 2026 |
| Current Closing Date for Applications: | Nov 02, 2026 |
| Archive Date: | Dec 08, 2026 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Public housing authorities/Indian housing authorities Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) State governments Special district governments Independent school districts For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-279.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357602 Full Announcement-PAR-24-279 -> PAR-24-279-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289528 | Feb 04, 2025 | Nov 02, 2026 | View |
Package 1
Mandatory forms
357602 RR_SF424_5_0-5.0.pdf
357602 PHS398_CoverPageSupplement_5_0-5.0.pdf
357602 RR_OtherProjectInfo_1_4-1.4.pdf
357602 PerformanceSite_4_0-4.0.pdf
357602 RR_KeyPersonExpanded_4_0-4.0.pdf
357602 PHS398_ResearchPlan_5_0-5.0.pdf
357602 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357602 RR_Budget_3_0-3.0.pdf
357602 RR_SubawardBudget30_3_0-3.0.pdf
357602 PHS398_ModularBudget_1_2-1.2.pdf
357602 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
